Search research articles
Contact Us
Filters
Showing results (331-340 of 380) with videos related to
Page
of 38
Sort By:
Infection and Immunity
|
October 1, 1992
Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi
M G Rittig, A Krause, T Häupl, et al.
Arthritis Research & Therapy
|
May 20, 2022
Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNFα therapy
S Hertrampf, J Klotsche, Q Schefer, et al.
Immunologic Research
|
September 16, 2016
Immunological characterization of the early human fracture hematoma
Paula Hoff, T Gaber, C Strehl, et al.
Clinical Pharmacology and Therapeutics
|
December 25, 2009
CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis
B Stuhlmüller, T Häupl, M M Hernandez, et al.
The British Journal of Dermatology
|
February 16, 2007
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists
H-H Lee, I-H Song, M Friedrich, et al.
Rheumatology (Oxford, England)
|
November 21, 2000
Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin
M Hundt, K Manger, T Dörner, et al.
Annals of the Rheumatic Diseases
|
March 14, 2002
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)
D E Furst, E C Keystone, F C Breedveld, et al.
Calcified Tissue International
|
June 29, 2010
Induced apoptosis of chondrocytes by Porphyromonas gingivalis as a possible pathway for cartilage loss in rheumatoid arthritis
E Röhner, J Detert, P Kolar, et al.
Zeitschrift Fur Rheumatologie
|
April 26, 2018
[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark]
T Häupl, A Skapenko, B Hoppe, et al.
Annals of the Rheumatic Diseases
|
November 12, 2010
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
M O Becker, C Brückner, H U Scherer, et al.
Page
of 38
Search research articles
Search
Showing results (331-340 of 380) with videos related to
Sort By:
Page
of 38
Infection and Immunity
|
October 1, 1992
Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi
M G Rittig, A Krause, T Häupl, et al.
Arthritis Research & Therapy
|
May 20, 2022
Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNFα therapy
S Hertrampf, J Klotsche, Q Schefer, et al.
Immunologic Research
|
September 16, 2016
Immunological characterization of the early human fracture hematoma
Paula Hoff, T Gaber, C Strehl, et al.
Clinical Pharmacology and Therapeutics
|
December 25, 2009
CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis
B Stuhlmüller, T Häupl, M M Hernandez, et al.
The British Journal of Dermatology
|
February 16, 2007
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists
H-H Lee, I-H Song, M Friedrich, et al.
Rheumatology (Oxford, England)
|
November 21, 2000
Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin
M Hundt, K Manger, T Dörner, et al.
Annals of the Rheumatic Diseases
|
March 14, 2002
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)
D E Furst, E C Keystone, F C Breedveld, et al.
Calcified Tissue International
|
June 29, 2010
Induced apoptosis of chondrocytes by Porphyromonas gingivalis as a possible pathway for cartilage loss in rheumatoid arthritis
E Röhner, J Detert, P Kolar, et al.
Zeitschrift Fur Rheumatologie
|
April 26, 2018
[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark]
T Häupl, A Skapenko, B Hoppe, et al.
Annals of the Rheumatic Diseases
|
November 12, 2010
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study
M O Becker, C Brückner, H U Scherer, et al.
Page
of 38